Indian Drugmaker Morepen Nabs $100M From Corinth Group
Private investment firm Corinth Group has agreed to plug $100 million into India-based pharmaceutical company Morepen Group, which will use the capital to boost its research and development capabilities and build...To view the full article, register now.
Already a subscriber? Click here to view full article